Procter & Gamble
PG
$150.59
+1.87%
Procter & Gamble is a global consumer staples manufacturer whose portfolio spans fabric and home care (Tide, Ariel, Downy), baby, feminine and family care (Pampers, Always, Charmin), beauty (Pantene, Olay, SK-II), grooming (Gillette, Braun), and health care (Oral-B, Vicks), sold in more than 180 countries with roughly half of consolidated sales generated outside the United States. As one of the world's largest and most durable branded consumer franchises — with more than 20 billion-dollar brands and a 188-year operating history — P&G is best characterized as a mature, cash-generative market leader whose competitive moat rests on scale, shelf-space dominance, pricing power, and an unrivaled dividend record as a Dividend King. The current investor debate centers on a visible growth stall: fiscal Q4 2026 revenue of $21.2 billion grew only 1.5% year over year, and management's fiscal 2027 guidance came in below consensus, citing roughly $1.36 billion in cost headwinds, which has kept the stock pinned near the bottom of its 52-week range even as the broader market rallied. Bulls frame the setup as a defensive, high-yield mean-reversion opportunity as the "Magnificent Seven" trade fractures and capital rotates toward consumer staples, while bears argue that without a return of positive volume growth, P&G risks remaining a low-growth, multiple-compression story.…
PG
Procter & Gamble
$150.59
Related headlines
Investment Opinion: Should I buy PG Today?
The synthesized recommendation is Hold. PG is a high-quality defensive staple with a strong dividend and analyst consensus target of $160.61, but its near-term growth stagnation and premium valuation limit upside. The stock is fairly valued at a forward P/E of 19.6, and while the 2.88% dividend yield provides income, total return potential is modest without a return to volume growth.
Supporting evidence includes: 1) Revenue growth of just 1.5% year over year in Q4 2026, well below the sector average; 2) Net margin of 18.4% and ROE of 29.5%, demonstrating strong profitability; 3) Free cash flow of $15.9 billion, comfortably covering the dividend with a 63.8% payout ratio; 4) Analyst average target of $160.61 implies 10.8% upside, but the low target of $143.00 is near the current price. The valuation metrics—P/E of 21.7, P/S of 4.08, and EV/EBITDA of 17.9—are at a premium to the broader market and historical averages for PG, reflecting its defensive quality but also limiting multiple expansion potential.
The biggest risks are: 1) Continued volume declines and cost headwinds could pressure earnings; 2) Multiple compression if growth does not accelerate; 3) Competitive threats from private labels and other consumer staples. The rating would upgrade to Buy if PG returns to positive volume growth and margins stabilize, or if the stock drops below $130 (approaching the 52-week low). It would downgrade to Sell if revenue growth turns negative or if the dividend payout ratio exceeds 70% without earnings growth. Overall, PG appears fairly valued relative to its history and peers, offering limited upside but downside protection.
Sign up to view all
PG 12-Month Price Forecast
PG presents a balanced risk/reward profile with a neutral stance. The company's defensive characteristics, strong dividend, and low beta are offset by stagnant revenue growth, cost headwinds, and a premium valuation. The base case (55% probability) targets $155-165, implying modest upside. A return to volume growth would be a key upgrade catalyst, while continued stagnation could lead to a downgrade. The stock is suitable for income-oriented investors but offers limited capital appreciation potential in the near term.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $160.78 and implied upside of +6.8% versus the current price.
Average Target
$160.78
0 analysts
Implied Upside
+6.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$143 - $186
Analyst target range
Bulls vs Bears: PG Investment Factors
The bear case currently has stronger evidence due to PG's anemic 1.5% revenue growth, below-consensus fiscal 2027 guidance, and significant relative underperformance versus the S&P 500. However, the bull case rests on PG's defensive characteristics, high dividend yield, and analyst expectations of a rebound, with a consensus target of $160.61 implying double-digit upside. The single most important tension is whether PG can return to positive volume growth; without it, the stock may remain a value trap with a premium multiple. If volume growth resumes, the narrative could shift quickly toward a mean-reversion rally, but continued stagnation would likely lead to further multiple compression.
Bullish
- Dividend King with 2.88% yield: PG offers a 2.88% dividend yield with a sustainable 63.8% payout ratio, backed by $15.9 billion in trailing free cash flow. This provides a reliable income stream and downside support, especially as the stock trades near its 52-week low of $137.62.
- Defensive low-beta staple: With a beta of just 0.377, PG is significantly less volatile than the broader market, making it an attractive defensive holding during periods of economic uncertainty. Its non-discretionary product mix ensures steady demand across economic cycles.
- Analyst consensus upside: The average analyst target price of $160.61 implies roughly 10.8% upside from the current price of $144.91, with a high target of $186.00. The consensus recommendation is 'buy' (mean 2.2), suggesting that analysts see value despite near-term headwinds.
- Strong profitability and ROE: PG maintains a robust net margin of 18.4% and an impressive return on equity of 29.5%, reflecting its pricing power and efficient capital allocation. Gross margin stands at 50.2%, underscoring the strength of its premium brands.
Bearish
- Stalling revenue growth: Fiscal Q4 2026 revenue grew only 1.5% year over year to $21.2 billion, and management's fiscal 2027 guidance came in below consensus. Without a return to positive volume growth, PG risks remaining a low-growth story.
- Cost headwinds pressure margins: Management cited approximately $1.36 billion in cost headwinds for fiscal 2027, which could compress margins and limit earnings growth. Gross margin already declined to 48.5% in Q4 2026 from 51.4% in Q1 2026, showing sequential deterioration.
- Premium valuation vs. growth: PG trades at a trailing P/E of 21.7 and a forward P/E of 19.6, with a PEG ratio of 18.1, indicating that the market is paying a high price for very modest growth. The price-to-sales ratio of 4.08 and EV/EBITDA of 17.9 are rich for a company growing revenue at 1.5%.
- Relative underperformance: PG has underperformed the S&P 500 significantly, with a 1-year relative strength of -19.7% and a 3-month relative strength of -7.6%. The stock is down 4.7% over the past year while the S&P 500 gained 15.0%, highlighting weak momentum.
PG Technical Analysis
Beta
0.38
0.38x market volatility
Max Drawdown
-16.1%
Largest decline past year
52-Week Range
$138-$167
Price range past year
Annual Return
-0.1%
Cumulative gain past year
| Period | PG Return | S&P 500 |
|---|---|---|
| 1m | +3.4% | +1.0% |
| 3m | +2.4% | +2.5% |
| 6m | +3.7% | +13.9% |
| 1y | -0.1% | +15.0% |
| ytd | +6.2% | +13.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PG Fundamental Analysis
Quarterly Revenue
$21.2B
2026-06
Revenue YoY Growth
+1.5%
YoY Comparison
Gross Margin
48.5%
Latest Quarter
Free Cash Flow
$15.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PG Overvalued?
PE
21.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~31x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.6x
Enterprise Value Multiple
Investment Risk Disclosure
PG faces financial and operational risks primarily from its slowing growth and margin pressure. Revenue grew only 1.5% year over year in Q4 2026, and management guided fiscal 2027 below consensus due to $1.36 billion in cost headwinds. Gross margin declined to 48.5% in Q4 2026 from 51.4% in Q1 2026, indicating sequential erosion. Additionally, the current ratio of 0.68 suggests potential liquidity tightness, and interest expense of $677 million in Q4 2026 adds a fixed burden. These factors could limit earnings growth and cash flow generation if not addressed.
Market and competitive risks include PG's premium valuation relative to its growth prospects. The stock trades at a trailing P/E of 21.7 and a forward P/E of 19.6, with a PEG ratio of 18.1, which is expensive for a company growing revenue at 1.5%. With a beta of 0.377, PG is less sensitive to market swings, but it still faces sector rotation risk; if investors continue to favor tech and growth stocks, PG may continue to underperform. Recent news highlights a potential rotation into consumer staples as the 'Magnificent Seven' trade fractures, but this is not guaranteed. Competitive pressures from private labels and other consumer goods companies could also limit pricing power.
In a worst-case scenario, PG could face a combination of persistent volume declines, further cost inflation, and multiple compression. If revenue growth turns negative and margins contract further, the stock could retest its 52-week low of $137.62, representing a downside of approximately 5% from the current price of $144.91. A more severe scenario, such as a recession that disproportionately impacts consumer spending or a failed product innovation cycle, could push the stock toward the analyst low target of $143.00, though that is only slightly below current levels. The maximum drawdown over the past period was -16.15%, indicating that a decline to around $121.50 is possible in a severe market downturn, which would be a 16% loss from current levels.
FAQ
The key risks include: 1) Financial risks: slowing revenue growth (1.5% YoY) and $1.36 billion in cost headwinds could pressure margins and earnings; 2) Valuation risk: a premium P/E of 21.7 and PEG of 18.1 leave little room for error, and any growth disappointment could trigger multiple compression; 3) Competitive risk: private-label brands and peers like Kimberly-Clark could erode market share; 4) Macro risk: with a beta of 0.377, PG is defensive, but rising interest rates could make its 2.88% dividend yield less attractive relative to bonds. The most severe risk is a sustained decline in volume growth, which could lead to a retest of the 52-week low of $137.62.
The 12-month forecast for PG is neutral with a slight bullish bias. The base case (55% probability) targets $155-165, aligned with the analyst average of $160.61, assuming modest revenue growth and stable margins. The bull case (25% probability) targets $170-186, driven by a return to volume growth and a rotation into staples. The bear case (20% probability) targets $130-143, if cost headwinds persist and growth stalls. The most likely scenario is the base case, with a key assumption that PG delivers 1-2% revenue growth and maintains its dividend. The stock is expected to trade in a range, with limited upside unless volume growth returns.
PG appears fairly valued to slightly overvalued relative to its growth prospects. The trailing P/E of 21.7 and forward P/E of 19.6 are at a premium to the broader market, and the PEG ratio of 18.1 suggests the market is paying a high price for low growth. The price-to-sales ratio of 4.08 and EV/EBITDA of 17.9 are also elevated for a company growing revenue at 1.5%. Compared to its own history, PG's valuation is in line with its 5-year average, but without an acceleration in growth, multiple expansion is unlikely. The market appears to be pricing in stability and dividend safety rather than growth.
PG can be a good buy for income-oriented investors seeking a reliable dividend and low volatility, but it may not be ideal for those seeking high growth. The stock offers a 2.88% dividend yield and trades at a forward P/E of 19.6, with analyst targets implying 10.8% upside to $160.61. However, revenue growth of only 1.5% and $1.36 billion in cost headwinds pose near-term risks. The biggest downside risk is a retest of the 52-week low of $137.62, about 5% below the current price. For long-term investors comfortable with modest total returns, PG is a solid defensive holding, but it may lag in a strong bull market.
PG is best suited for long-term investment, particularly for income-focused investors. Its low beta of 0.377 and reliable dividend make it a stable core holding, but its growth stagnation limits short-term trading opportunities. The stock has underperformed the S&P 500 over the past year (-4.7% vs. +15.0%), and momentum is weak. A minimum holding period of 3-5 years is recommended to benefit from dividend compounding and potential mean reversion. Short-term traders may find better opportunities elsewhere, as PG lacks catalysts for a quick rally. However, for those seeking defensive exposure and steady income, PG remains a solid long-term choice.